Meridien Reserach is recruiting overweight and obese participants with prediabetes or metformin-treated Type 2 Diabetes for a clinical research study investigating a product in capsule, Gelesis200.
If you would like to participate in a clinical research study testing the effect of Gelesis200, where you will receive dietary counselling for a weight loss, we would like to hear from you.
Gelesis200, administered in capsules, contains two natural food ingredients. The study is investigating if capsules containing Gelesis200 can promote your weight loss. The capsules should be ingested daily before breakfast, lunch, and dinner.